Real-World Experience of Using Next-Generation-Sequencing in Multiple Myeloma Diagnostics in the UK National Health Service.
The IMS-IMWG 2025 updated definition of high-risk multiple myeloma (HRMM) introduced next-generation sequencing (NGS) based detection of TP53 single-nucleotide variants (SNV) as an independent high-risk factor. However, most published data on TP53 SNVs in MM derive from exploratory research studies using NGS interpreta...